Article
Gene expression and immune infiltration in melanoma patients with different mutation burden.
BMC cancer - 9 Apr 2021
Wang Liwei, Chen Fu, Liu Rui, Shi Lei, Zhao Guosheng, Yan Zhengjian
Abstract excerpt
BACKGROUND: Immunotherapy is a vital component in cancer treatment. However, due to the complex genetic bases of cancer, a clear prediction index for efficacy has not been established. Tumor mutation burden (TMB) is one of the essential factors that affect immunotherapeutic efficacies, but it has not been determined whether the mutation is associated with the survival of Skin Cutaneous Melanoma (SKCM) patients....
Topics
- Aged
- Algorithms
- Biomarkers, Tumor
- Databases, Genetic
- Disease Susceptibility
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Kaplan-Meier Estimate
- Lymphocytes, Tumor-Infiltrating
- Male
